Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Joshi et al1 have evaluated the long-term safety of Praneem, a candidate vaginal microbicide by a randomised phase II clinical trial in Pune, India. They have found that Praneem polyherbal tablet is safe for vaginal use up to 6 months among low-risk women.1 In response to the above study we would like to mention here that another novel polyherbal formulation Basant, which contains purified diferuloylmethane (curcumin), purified extracts of Emblica officinalis (designated amla), purified aloe vera powder and rose extract water is also in the investigational stage.
Talwar et al2 have developed this novel polyherbal formulation, which qualifies for all the criteria of being a microbicide. Initially it was formulated as a cream …
Funding This study was financed by the Indian Council of Medical Research, New Delhi, India.
Competing interests None.
Contributors: ARB and AM wrote the letter. ARB performed the in vitro experiments under the supervision of AM. AG contributed in the formulations of tablet under the guidance of GPT. All co-authors made inputs, reviewed and finally approved this letter.
Provenance and Peer review Not commissioned; externally peer reviewed.